UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Strata Wealth Advisors LLC

Strata Wealth Advisors LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 5.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 938 shares of the healthcare conglomerate’s stock after selling 58 shares during the period. Strata Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $474,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in UNH. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at about $30,000. RPg Family Wealth Advisory LLC acquired a new stake in shares of UnitedHealth Group during the 3rd quarter valued at approximately $37,000. DecisionPoint Financial LLC increased its stake in UnitedHealth Group by 155.0% during the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after purchasing an additional 62 shares during the last quarter. Highline Wealth Partners LLC bought a new position in shares of UnitedHealth Group in the 3rd quarter worth about $55,000. Finally, Legacy Investment Solutions LLC bought a new stake in shares of UnitedHealth Group during the 3rd quarter valued at about $57,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Down 4.2 %

Shares of UNH opened at $501.52 on Wednesday. The company has a 50-day moving average price of $521.08 and a two-hundred day moving average price of $562.03. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The stock has a market cap of $461.54 billion, a price-to-earnings ratio of 32.36, a P/E/G ratio of 1.43 and a beta of 0.61. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $5.83 EPS. Equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of research reports. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research report on Friday, January 10th. KeyCorp reaffirmed an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Piper Sandler dropped their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Barclays cut their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. Finally, Wells Fargo & Company decreased their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. One research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat, UnitedHealth Group currently has a consensus rating of “Buy” and a consensus target price of $629.32.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The shares were bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this link. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.